RTS Life Science Launches Revolutionary Blood Fractionation System

1 post / 0 new
Shizank
Shizank's picture
RTS Life Science Launches Revolutionary Blood Fractionation System

RTS Life Science Launches Revolutionary Automated Blood Fractionation System at European Spring Biobanking and Biorepositories 2008

Manchester, UK (February 29 2008) RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems, today announces that it will be launching its revolutionary Automated Blood Fractionation (ABF) system at European Spring Biobanking and Biorepositories 2008,15-16 April, Zurich, Switzerland. This unique patent-pending* high throughput blood fractionation system is used to extract buffy coat (white blood cells) from whole blood samples.
The innovative, upgradable system provides a fully automated solution to blood fractionation and processing. The ABF system is a self-contained unit capable of processing up to 500 samples per day, providing substantial time and labour cost savings compared with manual fractionation. In addition, this new automated system from RTS Life Science provides the benefits of cost and labour saving, removal of human error, increased reproducibility and facilitation of sample tracking and auditing.

The revolutionary ABF system incorporates unique Vision System technology which measures the height of each fraction and calculates the volume of each layer following fractionation via centrifugation. The ABF solution also offers significant health and safety benefits by reducing employee exposure to unscreened blood and a LIMS (Laboratory Information Management System) interface ensures ease of acquisition and manipulation of data.

Kristian Spreckley, Blood Fractionation Product Manager at RTS Life Science comments, RTS has developed this new ABF system in response to the unique needs of the biobanking industry. The system should be installed to automate blood fractionation and buffy coat retrieval from whole blood in any high volume environment.

As well as the fully Automated Blood Fractionation System, RTS also offers this solution as a semi-automated system. To be among the first to see this innovative new offering from RTS Life Science please visit Biobanking and Biorepositories 2008, 15-16 April, Zurich, Switzerland.
More information about RTS Life Science is available at www.rtslifescience.com or by e-mail eval(unescape('%64%6f%63%75%6d%65%6e%74%2e%77%72%69%74%65%28%27%3c%61%20%68%72%65%66%3d%22%6d%61%69%6c%74%6f%3a%6c%69%66%65%73%63%69%65%6e%63%65%2e%69%6e%66%6f%40%72%74%73%2d%67%72%6f%75%70%2e%63%6f%6d%22%3e%6c%69%66%65%73%63%69%65%6e%63%65%2e%69%6e%66%6f%40%72%74%73%2d%67%72%6f%75%70%2e%63%6f%6d%3c%2f%61%3e%27%29%3b')).
*Patent Application Number 0422358.2

About RTS Life Science:
RTS Life Science is a UK-based supplier of drug discovery and drug delivery automation solutions for large scale sample management and high throughput testing in laboratories. RTS Life Science is owned by Robotic Technology Systems PLC, an AIM-listed company.

For further press information please contact: Sophie Downend, The Scott Partnership, 1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA United Kingdom Tel: + 44 1477 539539 Fax: +44 1477 539540 e-mail to: eval(unescape('%64%6f%63%75%6d%65%6e%74%2e%77%72%69%74%65%28%27%3c%61%20%68%72%65%66%3d%22%6d%61%69%6c%74%6f%3a%72%74%73%40%73%63%6f%74%74%70%72%2e%63%6f%6d%22%3e%72%74%73%40%73%63%6f%74%74%70%72%2e%63%6f%6d%3c%2f%61%3e%27%29%3b'))